Table 2.
Antimicrobial Agent | Dilution Range (μg/mL) | Susceptibility Break Points (μg/mL) | ||
---|---|---|---|---|
Susceptible | Intermediate | Resistant | ||
Penicillina | 0.03–64 | ≤0.12 | ≥0.25 | |
Oxacillinb | 0.03–64 | ≤2 | ≥4 | |
Sulfamethoxazolea | 0.12–128 | ≤64 | ≥128 | |
Tetracyclinea | 0.03–64 | ≤4 | 8 | ≥16 |
Enrofloxacina | 0.03–16 | ≤0.25 | 0.5–1 | ≥2 |
Amoxicillin/clavulanateb | 0.03–64 | ≤2 | 2/4 | ≥8 |
Cefalexind | 0.03–64 | ≤2 | 4 | ≥8 |
Ceftiofura | 0.03–64 | ≤24 | 4 | ≥8 |
Clindamycinb | 0.03–64 | ≤2 | 1–2 | ≥4 |
Daptomycinc | 0.03–64 | ≤1 | 1–2 | ≥2 |
Notes: aInterpretative breakpoint based on the CLSI breakpoints used in veterinary medicine; binterpretative breakpoint based on the CLSI breakpoints used in human medicine; cinterpretative break point based on EUCAST, 2015;44 dbreakpoint of cefalexin based on cephalothin.